PN PHARMACOLOGY FOR NURSING
COMPREHENSIVE EXAM STUDY GUIDE | CONTENT
MASTERY REVIEW MODULE | PRACTICE QUESTIONS
& ANSWERS WITH DETAILED RATIONALES | NCLEX-
PN EXAM PREP
SECTION 1: PHARMACOLOGICAL PRINCIPLES (Questions 1-30)
1. A nurse is preparing to administer a medication that has a high first-pass effect. The
nurse should anticipate that this medication will be administered by which route?
A. Sublingual
B. Intravenous
C. Oral
D. Transdermal
Answer: C
Rationale: Medications administered orally are absorbed from the gastrointestinal tract and
transported to the liver via the portal circulation, where they undergo extensive metabolism
before reaching systemic circulation. This first-pass effect significantly reduces the
bioavailability of orally administered drugs. Sublingual, intravenous, and transdermal
routes bypass the portal circulation and avoid first-pass metabolism.
2. A client asks the nurse how a medication taken orally reaches the target organ. The nurse
should explain that the process by which a drug moves from the site of administration into
the bloodstream is called:
,A. Distribution
B. Metabolism
C. Absorption
D. Excretion
Answer: C
Rationale: Absorption is the process by which a drug moves from its site of administration
into the bloodstream. Distribution refers to the transport of the drug from the bloodstream
to tissues and organs. Metabolism is the biotransformation of the drug into a more water-
soluble form for excretion. Excretion is the elimination of the drug from the body.
3. A nurse is reviewing the pharmacokinetics of a medication. The nurse should identify
that the half-life of a drug is defined as:
A. The time required for the drug to reach peak plasma concentration
B. The time required for the body to eliminate 50% of the drug
C. The time required for the drug to be completely eliminated from the body
D. The time required for the drug to bind to plasma proteins
Answer: B
Rationale: The half-life (t½) of a drug is the time required for the body to eliminate 50% of
the drug. It is a constant value that helps determine dosing intervals. Peak plasma
concentration is the maximum concentration achieved after administration. Complete
elimination typically requires approximately 5 half-lives. Protein binding affects
distribution, not half-life.
4. A nurse is caring for a client who has renal impairment. The nurse should anticipate that
the client may require adjustments in medication dosing because renal impairment affects
which pharmacokinetic phase?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Answer: D
,Rationale: The kidneys are the primary organs responsible for drug excretion. Renal
impairment reduces the clearance of medications that are eliminated renally, leading to
drug accumulation and potential toxicity. Dosage adjustments are often necessary to
prevent adverse effects. Absorption, distribution, and metabolism are not directly affected
by renal impairment to the same extent.
5. A nurse is teaching a client about a new medication. The nurse should explain that the
therapeutic index of a drug refers to:
A. The ratio between the drug's effectiveness and its cost
B. The ratio between the toxic dose and the therapeutic dose
C. The amount of drug needed to produce a therapeutic effect
D. The speed at which the drug produces its effects
Answer: B
Rationale: The therapeutic index (TI) is the ratio between a drug's toxic dose and its
therapeutic dose. A narrow therapeutic index indicates that the drug has a small margin of
safety, requiring close monitoring of serum drug levels. The therapeutic index does not
relate to cost, the amount needed for effect, or the speed of onset.
6. A nurse is administering a medication that is an agonist. The nurse should understand
that an agonist medication:
A. Blocks the receptor and prevents activation
B. Binds to the receptor and activates it
C. Binds to a different site on the receptor
D. Has no effect on the receptor
Answer: B
Rationale: An agonist is a medication that binds to a receptor and activates it, producing a
response. An antagonist blocks the receptor and prevents activation. Allosteric modulators
bind to a different site on the receptor. Medications that have no effect on the receptor are
not considered agonists.
7. A nurse is monitoring a client who is receiving a medication with a narrow therapeutic
index. Which of the following actions should the nurse take?
, A. Administer the medication with food to enhance absorption
B. Monitor serum drug levels regularly
C. Increase the dose if symptoms persist
D. Administer the medication at bedtime
Answer: B
Rationale: Medications with a narrow therapeutic index have a small margin of safety
between the therapeutic dose and the toxic dose. Regular monitoring of serum drug levels
is essential to ensure the drug remains within the therapeutic range and to prevent toxicity.
Administering with food, increasing the dose, or changing the administration time without
monitoring could lead to adverse effects.
8. A nurse is reviewing the medication administration record and notes that a client is
prescribed a medication that is a prodrug. The nurse should understand that a prodrug:
A. Is inactive until metabolized in the body
B. Is active immediately upon administration
C. Is excreted unchanged in the urine
D. Binds irreversibly to plasma proteins
Answer: A
Rationale: A prodrug is an inactive form of a medication that must be metabolized in the
body to become active. This design can improve bioavailability, reduce side effects, or
target specific tissues. Prodrugs are not active immediately upon administration. They are
not excreted unchanged, and they do not bind irreversibly to plasma proteins.
9. A nurse is preparing to administer a medication that is highly protein-bound. The nurse
should recognize that which of the following conditions could increase the risk of toxicity?
A. Hypoalbuminemia
B. Hyperalbuminemia
C. Decreased liver function
D. Increased renal function
Answer: A
Rationale: Highly protein-bound medications are primarily bound to albumin in the
bloodstream. Hypoalbuminemia results in fewer protein-binding sites, leading to a higher
COMPREHENSIVE EXAM STUDY GUIDE | CONTENT
MASTERY REVIEW MODULE | PRACTICE QUESTIONS
& ANSWERS WITH DETAILED RATIONALES | NCLEX-
PN EXAM PREP
SECTION 1: PHARMACOLOGICAL PRINCIPLES (Questions 1-30)
1. A nurse is preparing to administer a medication that has a high first-pass effect. The
nurse should anticipate that this medication will be administered by which route?
A. Sublingual
B. Intravenous
C. Oral
D. Transdermal
Answer: C
Rationale: Medications administered orally are absorbed from the gastrointestinal tract and
transported to the liver via the portal circulation, where they undergo extensive metabolism
before reaching systemic circulation. This first-pass effect significantly reduces the
bioavailability of orally administered drugs. Sublingual, intravenous, and transdermal
routes bypass the portal circulation and avoid first-pass metabolism.
2. A client asks the nurse how a medication taken orally reaches the target organ. The nurse
should explain that the process by which a drug moves from the site of administration into
the bloodstream is called:
,A. Distribution
B. Metabolism
C. Absorption
D. Excretion
Answer: C
Rationale: Absorption is the process by which a drug moves from its site of administration
into the bloodstream. Distribution refers to the transport of the drug from the bloodstream
to tissues and organs. Metabolism is the biotransformation of the drug into a more water-
soluble form for excretion. Excretion is the elimination of the drug from the body.
3. A nurse is reviewing the pharmacokinetics of a medication. The nurse should identify
that the half-life of a drug is defined as:
A. The time required for the drug to reach peak plasma concentration
B. The time required for the body to eliminate 50% of the drug
C. The time required for the drug to be completely eliminated from the body
D. The time required for the drug to bind to plasma proteins
Answer: B
Rationale: The half-life (t½) of a drug is the time required for the body to eliminate 50% of
the drug. It is a constant value that helps determine dosing intervals. Peak plasma
concentration is the maximum concentration achieved after administration. Complete
elimination typically requires approximately 5 half-lives. Protein binding affects
distribution, not half-life.
4. A nurse is caring for a client who has renal impairment. The nurse should anticipate that
the client may require adjustments in medication dosing because renal impairment affects
which pharmacokinetic phase?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Answer: D
,Rationale: The kidneys are the primary organs responsible for drug excretion. Renal
impairment reduces the clearance of medications that are eliminated renally, leading to
drug accumulation and potential toxicity. Dosage adjustments are often necessary to
prevent adverse effects. Absorption, distribution, and metabolism are not directly affected
by renal impairment to the same extent.
5. A nurse is teaching a client about a new medication. The nurse should explain that the
therapeutic index of a drug refers to:
A. The ratio between the drug's effectiveness and its cost
B. The ratio between the toxic dose and the therapeutic dose
C. The amount of drug needed to produce a therapeutic effect
D. The speed at which the drug produces its effects
Answer: B
Rationale: The therapeutic index (TI) is the ratio between a drug's toxic dose and its
therapeutic dose. A narrow therapeutic index indicates that the drug has a small margin of
safety, requiring close monitoring of serum drug levels. The therapeutic index does not
relate to cost, the amount needed for effect, or the speed of onset.
6. A nurse is administering a medication that is an agonist. The nurse should understand
that an agonist medication:
A. Blocks the receptor and prevents activation
B. Binds to the receptor and activates it
C. Binds to a different site on the receptor
D. Has no effect on the receptor
Answer: B
Rationale: An agonist is a medication that binds to a receptor and activates it, producing a
response. An antagonist blocks the receptor and prevents activation. Allosteric modulators
bind to a different site on the receptor. Medications that have no effect on the receptor are
not considered agonists.
7. A nurse is monitoring a client who is receiving a medication with a narrow therapeutic
index. Which of the following actions should the nurse take?
, A. Administer the medication with food to enhance absorption
B. Monitor serum drug levels regularly
C. Increase the dose if symptoms persist
D. Administer the medication at bedtime
Answer: B
Rationale: Medications with a narrow therapeutic index have a small margin of safety
between the therapeutic dose and the toxic dose. Regular monitoring of serum drug levels
is essential to ensure the drug remains within the therapeutic range and to prevent toxicity.
Administering with food, increasing the dose, or changing the administration time without
monitoring could lead to adverse effects.
8. A nurse is reviewing the medication administration record and notes that a client is
prescribed a medication that is a prodrug. The nurse should understand that a prodrug:
A. Is inactive until metabolized in the body
B. Is active immediately upon administration
C. Is excreted unchanged in the urine
D. Binds irreversibly to plasma proteins
Answer: A
Rationale: A prodrug is an inactive form of a medication that must be metabolized in the
body to become active. This design can improve bioavailability, reduce side effects, or
target specific tissues. Prodrugs are not active immediately upon administration. They are
not excreted unchanged, and they do not bind irreversibly to plasma proteins.
9. A nurse is preparing to administer a medication that is highly protein-bound. The nurse
should recognize that which of the following conditions could increase the risk of toxicity?
A. Hypoalbuminemia
B. Hyperalbuminemia
C. Decreased liver function
D. Increased renal function
Answer: A
Rationale: Highly protein-bound medications are primarily bound to albumin in the
bloodstream. Hypoalbuminemia results in fewer protein-binding sites, leading to a higher
